Shire Acquisitions Investments Ireland DAC, founded in Ireland, serves to facilitate investment opportunities as a subsidiary of Takeda Pharmaceutical Company from Japan. The company specializes in bond issuance, providing retail investors access to fixed-income securities linked with its broader investment strategy.
| Bond Name | Country | Maturity | Coupon(%) | |
|---|---|---|---|---|
| TACHEM 3.20% 2026-09-23 USDShire Acquisitions Investments Ireland DAC | United States | 2026-09-23 | 3.200 | 3.80 |
Company overview and issue history are AI generated, and should not be cited or relied on without verification.
Since its inception, Shire Acquisitions has been proactive in bond issuance, with its first notable offering occurring in 2016, which was aimed at funding strategic acquisitions and operational growth. In 2021, the company launched a high-demand bond series with a competitive yield of 3.5%, outperforming the industry average at the time. The bonds are characterized by robust repayment terms, and recently, Shire Acquisitions received favorable credit rating upgrades, bolstering investor confidence amid ongoing market developments.